| The 2016 European Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy L Bartalena, L Baldeschi, K Boboridis, A Eckstein, GJ Kahaly, C Marcocci, ... European thyroid journal 5 (1), 9-26, 2016 | 1007 | 2016 |
| Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO L Bartalena, L Baldeschi, A Dickinson, A Eckstein, P Kendall-Taylor, ... European Journal of Endocrinology 158 (3), 273-285, 2008 | 880 | 2008 |
| Selenium and the course of mild Graves' orbitopathy C Marcocci, GJ Kahaly, GE Krassas, L Bartalena, M Prummel, M Stahl, ... New England Journal of Medicine 364 (20), 1920-1931, 2011 | 733 | 2011 |
| Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy L Bartalena, L Baldeschi, AJ Dickinson, A Eckstein, P Kendall-Taylor, ... Thyroid 18 (3), 333-346, 2008 | 604 | 2008 |
| Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting C Baudouin, P Aragona, EM Messmer, A Tomlinson, M Calonge, ... The ocular surface 11 (4), 246-258, 2013 | 544 | 2013 |
| Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction C Baudouin, EM Messmer, P Aragona, G Geerling, YA Akova, ... British Journal of Ophthalmology 100 (3), 300-306, 2016 | 528 | 2016 |
| Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey D McKeag, C Lane, JH Lazarus, L Baldeschi, K Boboridis, AJ Dickinson, ... British Journal of Ophthalmology 91 (4), 455-458, 2007 | 355 | 2007 |
| Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy L Bartalena, GE Krassas, WM Wiersinga, C Marcocci, M Salvi, ... The Journal of Clinical Endocrinology & Metabolism 97 (12), 4454-4463, 2012 | 323 | 2012 |
| Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers European journal of endocrinology 155 (3), 387-389, 2006 | 323 | 2006 |
| Role of corneal nerves in ocular surface homeostasis and disease M Labetoulle, C Baudouin, M Calonge, J Merayo‐Lloves, KG Boboridis, ... Acta ophthalmologica 97 (2), 137-145, 2019 | 198 | 2019 |
| European Group on Graves’ Orbitopathy (EUGOGO). The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy L Bartalena, L Baldeschi, K Boboridis, A Eckstein, GJ Kahaly, C Marcocci, ... Eur Thyroid J 5 (1), 9-26, 2016 | 186 | 2016 |
| Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement P Perros, L Hegedüs, L Bartalena, C Marcocci, GJ Kahaly, L Baldeschi, ... Orphanet journal of rare diseases 12, 1-6, 2017 | 180 | 2017 |
| Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the OCEAN group meeting G Geerling, C Baudouin, P Aragona, M Rolando, KG Boboridis, ... The ocular surface 15 (2), 179-192, 2017 | 178 | 2017 |
| Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures MP Mourits, HM Bijl, MA Altea, L Baldeschi, K Boboridis, N Currò, ... British Journal of Ophthalmology 93 (11), 1518-1523, 2009 | 169 | 2009 |
| Surgical orbital decompression for thyroid eye disease KG Boboridis, C Bunce Cochrane Database of Systematic Reviews, 2011 | 120 | 2011 |
| Twenty-four–Hour Control With Latanoprost-Timolol–Fixed Combination Therapy vs Latanoprost Therapy AGP Konstas, K Boboridis, D Tzetzi, K Kallinderis, JN Jenkins, ... Archives of Ophthalmology 123 (7), 898-902, 2005 | 99 | 2005 |
| Long‐term follow up of autologous serum treatment for recurrent corneal erosions NG Ziakas, KG Boboridis, C Terzidou, TL Naoumidi, D Mikropoulos, ... Clinical & experimental ophthalmology 38 (7), 683-687, 2010 | 95 | 2010 |
| European Group on Graves’ Orbitopathy. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves … L Bartalena, GE Krassas, W Wiersinga, C Marcocci, M Salvi, C Daumerie, ... J Clin Endocrinol Metab 97 (12), 4454-4463, 2012 | 93 | 2012 |
| Visual acuity and quality of life in dry eye disease: Proceedings of the OCEAN group meeting J Benítez-del-Castillo, M Labetoulle, C Baudouin, M Rolando, YA Akova, ... The ocular surface 15 (2), 169-178, 2017 | 91 | 2017 |
| A questionnaire survey on the management of Graves' orbitopathy in Europe European Journal of Endocrinology 155 (2), 207-211, 2006 | 90 | 2006 |
Petros PERROSHonorary Senior Lecturer, Institute of genetic Medicine, Newcastle University在 ncl.ac.uk 的电子邮件经过验证
